Both in Pharmaceuticals
Nurix Therapeutics vs Generate Biomedicines
Over the past year NRIX returned −36.5% and GENB returned −9.9%; their daily moves had a correlation of 0.09.
NRIX −36.5% GENB −9.9%Growth of $1, one year, split-adjusted
| Metric | NRIX | GENB |
|---|---|---|
| Price | $15.95 | $14.16 |
| Market cap | $1.74B | $1.82B |
| Today | −38.23% | +2.24% |
| 1 month | −29.4% | +2.6% |
| 6 months | −5.5% | — |
| Year to date | −15.9% | — |
| 1 year | +26.4% | — |
| Revenue growth (YoY) | +8426.3% | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | 81.7% | −1065.2% |
| P/E (TTM) | 5.9× | — |
| Price / sales | 2.5× | — |
| Net cash | $1.05B | $452.3M |
| Dividend yield | — | — |
| Volatility (60d) | 104.6% | — |
| Short % of float | 21.0% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).